Tobacco Education and Lung Health Study (TEAL)
Primary Objective To compare two smoking cessation interventions among individuals undergoing lung cancer screening. Primary outcomes are: 3-month self-reported abstinence from cigarettes and 6-month self-reported and bioverified abstinence from cigarettes. Secondary Objectives 1) To evaluate reach and engagement overall and by subgroup (e.g., race and ethnicity, underinsured, readiness to quit). 2) To conduct an economic analysis to evaluate intervention costs from the health system perspective.
Checked against the public recordLast updated Feb 17, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Phase 3
- Sponsor
- Georgetown University
- Interventions being studied
- Behavioral: Phone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention; Behavioral: E-Referral to the Tobacco Quitline
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * eligible for a screening or diagnostic scan, * USPSTF eligibility criteria (50-80 years old and \>20-pack years); * currently smoking cigarettes (\>1 in the past 30 days); * English speaking; * able to provide meaningful consent. Exclusion Criteria: * prior lung cancer, * hearing impairment, * cognitive impairment, * household member already enrolled.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Georgetown University Medical CenterWashington D.C., District of Columbia
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 17, 2026. Always confirm current availability with the study team.